NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

European Stocks Fall Amid Ongoing Trade Uncertainty

Market Overview European stocks declined on Tuesday, with the Stoxx Europe 600 Index down 0.3% at 8:18 a.m. in London. The market's performance follows the introduction of President Donald Trump's new 10% global tariffs, which has added to investor uncertainty.

Sector Performance The automakers and chemicals sectors led gains, while insurance and bank shares lagged behind. Novo Nordisk A/S, a pharmaceutical company, dropped 3.8% after analyst downgrades, as data for its next-generation obesity shot CagriSema disappointed.

Trade Uncertainty The European Union has warned that some tariffs under the new policy will exceed the level permitted under the EU–US trade agreement. This has contributed to ongoing trade uncertainty, with investors remaining cautious despite the US Supreme Court's ruling striking down Trump's global tariffs.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Artificial Intelligence Concerns Uncertainty lingers about sectors deemed to be at risk of disruption from artificial intelligence. The technology-heavy US Nasdaq 100 slumped 1.2% on Monday.

Event Calendar An event hosted by Anthropic PBC, an AI tools maker, will take place on Tuesday, followed by Nvidia Corp.'s earnings later this week.

Market Outlook Investor confidence remains fragile, and the trajectory of European stocks is uncertain due to ongoing trade issues with the US. Portfolio manager Emma Moriarty warned that investor confidence could easily drift back into risk-off territory.

Investor Takeaway

Investors should remain cautious amid ongoing trade uncertainty and mixed earnings reports.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.